{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:01:47Z","timestamp":1740178907746,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol Exp"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s41747-018-0075-0","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T03:12:31Z","timestamp":1545016351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Changes in total choline concentration in the breast of healthy fertile young women in relation to menstrual cycle or use of oral contraceptives: a 3-T 1H-MRS study"],"prefix":"10.1186","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0954-2634","authenticated-orcid":false,"given":"Giovanni","family":"Di Leo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ileana","family":"Ioan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Laura","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Midulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franca","family":"Podo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Sardanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Pediconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,17]]},"reference":[{"doi-asserted-by":"crossref","unstructured":"Jacobs MA, Barker PB, Bottomley PA, Bhujwalla Z, Bluemke DA (2004) Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging 19:68\u201375","key":"75_CR1","DOI":"10.1002\/jmri.10427"},{"key":"75_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1148\/radiol.2362040836","volume":"236","author":"S Meisamy","year":"2005","unstructured":"Meisamy S, Bolan PJ, Baker EH et al (2005) Adding in vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T. Radiology 236:465\u2013475","journal-title":"Radiology"},{"key":"75_CR3","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1148\/radiol.2393051046","volume":"239","author":"L Bartella","year":"2006","unstructured":"Bartella L, Morris EA, Dershaw DD et al (2006) Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: Preliminary study. Radiology 239:686\u2013692","journal-title":"Radiology"},{"key":"75_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11547-008-0228-y","volume":"113","author":"F Sardanelli","year":"2008","unstructured":"Sardanelli F, Fausto A, Podo F (2008) MR spectroscopy of the breast. Radiol Med 113:56\u201364","journal-title":"Radiol Med"},{"doi-asserted-by":"crossref","unstructured":"Sardanelli F, Fausto A, Di Leo G, de Nijs R, Vorbuchner M, Podo F (2009) In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy. AJR Am J Roentgenol 192:1608\u20131617","key":"75_CR5","DOI":"10.2214\/AJR.07.3521"},{"key":"75_CR6","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/jnci\/94.16.1197","volume":"94","author":"R Katz-Brull","year":"2002","unstructured":"Katz-Brull R, Lavin PT, Lenkinski RE (2002) Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 94:1197\u20131203","journal-title":"J Natl Cancer Inst"},{"key":"75_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/nbm.1301","volume":"22","author":"C Mountford","year":"2009","unstructured":"Mountford C, Ramadan S, Stanwell P, Malycha P (2009) Proton MRS of the breast in the clinical setting. NMR Biomed 22:54\u201364","journal-title":"NMR Biomed"},{"key":"75_CR8","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1148\/radiol.13121856","volume":"267","author":"PA Baltzer","year":"2013","unstructured":"Baltzer PA, Dietzel M (2013) Breast lesions: diagnosis by using proton MR spectroscopy at 1.5 and 3.0 T \u2013 systematic review and meta-analysis. Radiology 267:735\u2013746","journal-title":"Radiology"},{"key":"75_CR9","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00432-014-1605-7","volume":"140","author":"D Cen","year":"2014","unstructured":"Cen D, Xu L (2014) Differential diagnosis between malignant and benign breast lesions using single-voxel proton MRS: a meta-analysis. J Cancer Res Clin Oncol 140:993\u20131001","journal-title":"J Cancer Res Clin Oncol"},{"doi-asserted-by":"crossref","unstructured":"Tan J, Xu L, Yao W, Wan Y, Zhou S, Xin SX (2015) In vivo post-contrast 1H-MRS evaluation of malignant and benign breast lesions: a meta-analysis. Tumour Biol 36:345\u2013352","key":"75_CR10","DOI":"10.1007\/s13277-014-2635-0"},{"key":"75_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s12032-015-0603-1","volume":"32","author":"X Wang","year":"2015","unstructured":"Wang X, Wang XJ, Song HS, Chen LH (2015) 1H-MRS evaluation of breast lesions by using total choline signal-to-noise ratio as an indicator of malignancy: a meta-analysis. Med Oncol 32:160","journal-title":"Med Oncol"},{"doi-asserted-by":"crossref","unstructured":"Sardanelli F, Carbonaro LA, Montemezzi S, Cavedon C, Trimboli RM (2016) Clinical breast MR using MRS or DWI: who is the winner? Front Oncol 6:217","key":"75_CR12","DOI":"10.3389\/fonc.2016.00217"},{"key":"75_CR13","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00330-004-2475-1","volume":"15","author":"P Stanwell","year":"2005","unstructured":"Stanwell P, Gluch L, Clark D et al (2005) Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T. Eur Radiol 15:1037\u20131043","journal-title":"Eur Radiol"},{"key":"75_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1148\/radiol.2512080553","volume":"251","author":"HM Baek","year":"2009","unstructured":"Baek HM, Chen JH, Nie K et al (2009) Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy. Radiology 251:653\u2013662","journal-title":"Radiology"},{"key":"75_CR15","first-page":"80","volume":"59","author":"EO Aboagye","year":"1999","unstructured":"Aboagye EO, Bhujwalla ZM (1999) Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 59:80\u201384","journal-title":"Cancer Res"},{"unstructured":"Vogel PM, Georgiade NG, Fetter BF, Vogel FS, McCarty KS Jr (1981) The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol 104:23\u201324","key":"75_CR16"},{"key":"75_CR17","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00330-008-0863-7","volume":"18","author":"RM Mann","year":"2008","unstructured":"Mann RM, Kuhl CK, Kinkel K, Boetes C (2008) Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol 18:1307\u20131318","journal-title":"Eur Radiol"},{"doi-asserted-by":"crossref","unstructured":"Jung Y, Jeong SK, Kang DK, Moon Y, Kim TH (2018) Quantitative analysis of background parenchymal enhancement in whole breast on MRI: influence of menstrual cycle and comparison with a qualitative analysis. Eur J Radiol 103:84\u201389","key":"75_CR18","DOI":"10.1016\/j.ejrad.2018.04.009"},{"doi-asserted-by":"crossref","unstructured":"Scaranelo AM, Carrillo MC, Fleming R, Jacks LM, Kulkarni SR, Crystal P (2013) Pilot study of quantitative analysis of background enhancement on breast MR images: association with menstrual cycle and mammographic breast density. Radiology 267:692\u2013700","key":"75_CR19","DOI":"10.1148\/radiol.13120121"},{"key":"75_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mri.2012.06.022","volume":"31","author":"TV Clendenen","year":"2013","unstructured":"Clendenen TV, Kim S, Moy L et al (2013) Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women. Magn Reson Imaging 31:1\u20139","journal-title":"Magn Reson Imaging"},{"key":"75_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0001-2998(75)80028-6","volume":"5","author":"SJ Goldsmith","year":"1975","unstructured":"Goldsmith SJ (1975) Radioimmunoassay: review of basic principles. Semin Nucl Med 5:125\u2013152","journal-title":"Semin Nucl Med"},{"key":"75_CR22","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.mric.2013.04.008","volume":"21","author":"PJ Bolan","year":"2013","unstructured":"Bolan PJ (2013) Magnetic resonance spectroscopy of the breast: current status. Magn Reson Imaging Clin N Am 21:625\u2013639","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"75_CR23","doi-asserted-by":"publisher","first-page":"S241","DOI":"10.1148\/rg.27si075504","volume":"27","author":"L Bartella","year":"2007","unstructured":"Bartella L, Huang W (2007) Proton (1H) MR spectroscopy of the breast. Radiographics 27:S241\u2013S252","journal-title":"Radiographics"},{"key":"75_CR24","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1148\/radiol.11101855","volume":"259","author":"MD Dorrius","year":"2011","unstructured":"Dorrius MD, Pijnappel RM, Jansen-van der Weide MC et al (2011) Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions. Radiology 259:695\u2013703","journal-title":"Radiology"},{"key":"75_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/nbm.1217","volume":"22","author":"IS Haddadin","year":"2009","unstructured":"Haddadin IS, McIntosh A, Meisamy S et al (2009) Metabolite quantification and high-field MRS in breast cancer. NMR Biomed 22:65\u201376","journal-title":"NMR Biomed"}],"container-title":["European Radiology Experimental"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-018-0075-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s41747-018-0075-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-018-0075-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T19:05:14Z","timestamp":1576523114000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurradiolexp.springeropen.com\/articles\/10.1186\/s41747-018-0075-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["75"],"URL":"https:\/\/doi.org\/10.1186\/s41747-018-0075-0","relation":{},"ISSN":["2509-9280"],"issn-type":[{"type":"electronic","value":"2509-9280"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"7 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional review board and all participants signed a written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Included in the informed consent obtained by the participants in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Francesco Sardanelli is the Editor-in-chief of <i>European Radiology Experimental<\/i>; for this reason, he was not involved in any way in the revision\/decision process, which was completely managed by the Deputy Editor, Dr. Akos Varga-Szemes (Medical University of South Carolina, Charleston, SC, USA). In addition, Francesco Sardanelli received research grants by General Electric Healthcare. The other authors have no competing interests related to the present paper to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"43"}}